Dealings in securities by directors, prescribed officers, the Company Secretary and the JSE LTIS 2018 Trust JSE LIMITED (Incorporated in the Republic of South Africa) Registration number: 2005/022939/06 Share Code: JSE ISIN: ZAE000079711 LEI: 213800MZ1VUQEBWRFO39 ("JSE") DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY SECRETARY AND THE JSE LTIS 2018 TRUST The JSE LTIS 2018 Trust ("Trust") has acquired 781 870 JSE ordinary shares in the open market on behalf of executive directors, prescribed officers, the Company Secretary, and senior members of staff ("LTIS 2018 participants") in respect of share awards granted in March 2024 to these LTIS 2018 participants under the JSE's Long-Term Incentive Scheme ("LTIS 2018"). The ordinary shares are held by the LTIS 2018 participants on a direct beneficial basis. These ordinary shares are restricted until all vesting criteria are fulfilled whereupon the shares will vest in the hands of LTIS 2018 participants. To the extent that the vesting criteria are not fulfilled, the share awards are forfeited. The vesting of these restricted JSE ordinary shares is subject to – (i) the JSE achieving specified corporate performance targets over the measurement period; and (ii) the LTIS 2018 participant remaining in the employ of the JSE for the vesting term (collectively "the vesting criteria"). These JSE ordinary shares were acquired on-market, with prior clearance and at a volume-weighted average price ("VWAP") of R89.61 per ordinary share. The total transaction value amounted to R70 061 395. The daily high, low and volume-weighted average price for the various transactions effected by the Trust were – Number of JSE Daily VWAP of Daily highest Daily lowest Dates in 2024 ordinary JSE shares price paid price paid that JSE shares acquired (cents per (cents per ordinary acquired (cents per share) share) shares were share) acquired 18 March 193 624 8851.36 8855 8765 19 March 117 683 9146.27 9206 8948 20 March 470 563 8959.36 9250 8964 The requisite approvals have been granted by shareholders at the JSE's annual general meeting, in respect of the acquisition of JSE ordinary shares in the open market and in respect of specific financial assistance to the Trust for the purpose of acquiring these ordinary shares. ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, PRESCRIBED OFFICERS AND THE COMPANY SECRETARY Following the acquisition of the JSE ordinary shares by the Trust as disclosed above, the executive directors, the prescribed officers and the Company Secretary have, on 20 March 2024, accepted grants of restricted JSE ordinary shares, as reflected below. Executive Role Total number Total Rand value Nature of of restricted of restricted JSE interest JSE ordinary ordinary shares shares awarded and awarded and accepted accepted L Fourie Group CEO & 148 310 13 290 059 Direct Executive beneficial Director F Suliman Group CFO & 60 080 5 383 768 Direct Executive beneficial Director A Greenwood Prescribed 58 398 5 233 044 Direct Officer beneficial V Lee Prescribed 31 082 2 785 258 Direct Officer beneficial I Monale Prescribed 45 394 4 067 756 Direct Officer beneficial Q Mthembu Prescribed 20 830 1 866 576 Direct Officer beneficial M Randall Prescribed 49 144 4 403 793 Direct Officer beneficial T Tsoaeli Prescribed 40 804 3 656 446 Direct Officer beneficial V Reddy Prescribed 64 886 5 814 434 Direct Officer beneficial GA Brookes Group Company 16 040 1 437 344 Direct Secretary beneficial The restricted shares will vest in two tranches, one-half on 1 March 2027 and the remaining half on 1 March 2028, subject to the vesting criteria as set out above being met. The individual allocations (grant and acceptance) were approved by the JSE's Group Remuneration Committee and clearance to deal was granted by the Chairman of the Board. Sandton 22 March 2024 Sponsor RAND MERCHANT BANK (A division of FirstRand Bank Limited) Date: 22-03-2024 05:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.